A recent Morbidity and Mortality Weekly Report published by the U.S. Centers for Disease Control and Prevention (CDC) confirmed the route of administration of the first dose of Bavarian Nordic JYNNEOS® (MVA-BN) vaccine was not associated with lower overall 2-dose series completion rates during the mpox outbreak in the U.S.
Read More